Search Ontology:
ChEBI
beta-D-Araf-(1->2)-alpha-D-Araf-(1->3)-[beta-D-Araf-(1->2)-alpha-D-Araf-(1->5)]-alpha-D-Araf-(1->5)-alpha-D-ArafOCH2CH2NHCOCH2[OCH2CH2]6NH2
- Term ID
- CHEBI:149624
- Synonyms
-
- 20-amino-N-(2-{[beta-D-arabinofuranosyl-(1->2)-alpha-D-arabinofuranosyl-(1->3)-[beta-D-arabinofuranosyl-(1->2)-alpha-D-arabinofuranosyl-(1->5)]-alpha-D-arabinofuranosyl-(1->5)-alpha-D-arabinofuranosyl]oxy}ethyl)-3,6,9,12,15,18-hexaoxaicosan-1-amide
- 23-amino-4-oxo-6,9,12,15,18,21-hexaoxa-3-azatricosan-1-yl beta-D-arabinofuranosyl-(1->2)-alpha-D-arabinofuranosyl-(1->3)-[beta-D-arabinofuranosyl-(1->2)-alpha-D-arabinofuranosyl-(1->5)]-alpha-D-arabinofuranosyl-(1->5)-alpha-D-arabinofuranoside
- 23-amino-4-oxo-6,9,12,15,18,21-hexaoxa-3-azatricosan-1-yl beta-D-arabinosyl-(1->2)-alpha-D-arabinosyl-(1->3)-[beta-D-arabinosyl-(1->2)-alpha-D-arabinosyl-(1->5)]-alpha-D-arabinosyl-(1->5)-alpha-D-arabinoside
- 23-amino-4-oxo-6,9,12,15,18,21-hexaoxa-3-azatricosan-1-yl hexaarabinofuranoside
- Ara6OCH2CH2NHCOCH2[OCH2CH2]6NH2
- Arabeta1-2Araalpha1-3[Arabeta1-2Araalpha1-5]Aralpha1-5AraalphaOCH2CH2NHCOCH2[OCH2CH2]6NH2
- Arabeta1->2Araalpha1->3[Arabeta1->2Araalpha1->5]Aralpha1->5AraalphaOCH2CH2NHCOCH2[OCH2CH2]6NH2
- beta-D-Ara-(1->2)-alpha-D-Ara-(1->3)-[beta-D-Ara-(1->2)-alpha-D-Ara-(1->5)]-alpha-D-Ara-(1->5)-alpha-D-AraOCH2CH2NHCOCH2[OCH2CH2]6NH2
- Definition
- A synthetic glycoside that consists of the branched hexasaccharide beta-D-Araf-(1->2)-alpha-D-Araf-(1->3)-[beta-D-Araf-(1->2)-alpha-D-Araf-(1->5)]-alpha-D-Araf-(1->5)-alpha-D-Araf having a 23-amino-4-oxo-6,9,12,15,18,21-hexaoxa-3-azatricosan-1-yl moiety at the reducing-end anomeric centre.
- References
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_functional_parent
-
Phenotype
Phenotype resulting from beta-D-Araf-(1->2)-alpha-D-Araf-(1->3)-[beta-D-Araf-(1->2)-alpha-D-Araf-(1->5)]-alpha-D-Araf-(1->5)-alpha-D-ArafOCH2CH2NHCOCH2[OCH2CH2]6NH2
Phenotype where environments contain beta-D-Araf-(1->2)-alpha-D-Araf-(1->3)-[beta-D-Araf-(1->2)-alpha-D-Araf-(1->5)]-alpha-D-Araf-(1->5)-alpha-D-ArafOCH2CH2NHCOCH2[OCH2CH2]6NH2
Phenotype modified by environments containing beta-D-Araf-(1->2)-alpha-D-Araf-(1->3)-[beta-D-Araf-(1->2)-alpha-D-Araf-(1->5)]-alpha-D-Araf-(1->5)-alpha-D-ArafOCH2CH2NHCOCH2[OCH2CH2]6NH2
Human Disease Model